Skip to content
Home/Companies/Biotech/Apmonia
Apmonia

Apmonia

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Apmonia?

Apmonia is a French Biotech company, currently owned by Capital Grand Est since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Capital Grand Est
Investor
Capital Grand Est
Cap Innov'Est 2 · 2021 · VC

Key facts

HQFrance
SectorBiotech
Websiteapmonia-therapeutics.com

More from Cap Innov'Est 2

Other portfolio companies in the same fund.

Elkedonia
Elkedonia
Active
BiotechFrance
Find Therapeutics
Find Therapeutics
Active
BiotechCanada
Keey Aerogel
Active
ConstructionFrance
Odimma
Odimma
Active
BiotechFrance
Superbranche
Superbranche
Active
HealthcareFrance
Dianosic
Active
MedTechFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Apmonia?

Apmonia is currently owned by Capital Grand Est, through Cap Innov'Est 2, since 2022.

When did Capital Grand Est acquire Apmonia?

Capital Grand Est acquired Apmonia in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue